October 4, 2023
Drug shortages drag on
Almost all hospital pharmacists reported facing drug shortages in a recent survey, but there are some available solutions, one expert says.
New COVID-19 boosters, biosimilar for MS OK’ed
The FDA approved updated COVID-19 vaccines and the first-ever biosimilar for multiple sclerosis (MS), among other recent actions.
Peripheral internal jugular catheters possible solution to difficult IV access
In a two-year pilot study involving 32 eligible patients at a U.S. academic hospital, 97% of peripheral internal jugular catheters were successfully placed with no complications.
Phase 3 trial finds new antibiotic noninferior to daptomycin for MRSA
An industry-funded trial compared ceftobiprole, a cephalosporin, to daptomycin plus optional aztreonam in adults with complicated Staphylococcus aureus bacteremia, including methicillin-resistant S. aureus (MRSA).
Most buprenorphine prescriptions not continued during hospitalization, VA study finds
An analysis of patients who had active buprenorphine prescriptions before a medical or surgical admission to a Veterans Administration (VA) hospital in 2018 to 2020 found that only 74.3% received a prescription for the drug in the 60 days after discharge.
1 in 3 adults with new-onset a fib during hospitalization have recurrence within a year
The findings suggest that patients who experience a transient episode of atrial fibrillation during hospitalization need risk stratification and follow-up, according to the authors of the matched cohort study.